首页> 外文期刊>The Journal of Physiology >Pre-exposure to adenosine, acting via A2A receptors on endothelial cells, alters the protein kinase A dependence of adenosine-induced dilation in skeletal muscle resistance arterioles
【24h】

Pre-exposure to adenosine, acting via A2A receptors on endothelial cells, alters the protein kinase A dependence of adenosine-induced dilation in skeletal muscle resistance arterioles

机译:预先暴露于腺苷,通过A2A受体作用于内皮细胞,改变了腺苷诱导的骨骼肌抵抗力小动脉的蛋白激酶A依赖性

获取原文
获取原文并翻译 | 示例
           

摘要

Adenosine (ADO) is an endogenous vasodilatory purine widely recognized to be a significant contributor to functional hyperaemia. Despite this, many aspects of the mechanisms by which ADO induces dilation in small resistance arterioles are not established, or appear contradictory. These include: identification of the primary receptor subtype; its location on endothelial (EC) or vascular smooth muscle cells; whether ADO acts on KATP channels in these resistance vessels; and the contribution of cAMP/protein kinase A (PKA) signalling to the response. In intravital microscopy studies of intact or EC-denuded skeletal muscle arterioles, we show that ADO acts via A2A receptors located on ECs to produce vasodilation via activation of KATP channels located on vascular smooth muscle cells. Importantly, we found that the signalling pathway involves cAMP as expected, but that a requirement for PKA activation is demonstrable only if the vessel is not pre-exposed to ADO. That is, PKA-dependent signalling varies with pre-exposure to ADO. Further, we show that PKA activation alone is not sufficient to dilate these arterioles; an additional EC calcium-dependent signalling mechanism is required for vasodilation to ADO. The ability of arterioles in situ to respond to occupancy of a specific receptor by utilizing different cell signalling pathways under different conditions to produce the same response allows the arteriole to respond to key homeostatic requirements using more than a single signalling mechanism. Clearly, this is likely to be physiologically advantageous, but the role for this signalling flexibility in the integrated arteriolar response that underlies functional hyperaemia will require further exploration.
机译:腺苷(ADO)是一种内源性血管舒张性嘌呤,被广泛认为是功能性充血的重要因素。尽管如此,ADO诱导小阻力小动脉扩张的机制的许多方面尚未建立,或似乎是矛盾的。这些包括:主要受体亚型的鉴定;它在内皮(EC)或血管平滑肌细胞上的位置; ADO是否作用于这些耐药血管中的KATP通道;以及cAMP /蛋白激酶A(PKA)信号对反应的贡献。在完整或EC裸露的骨骼肌小动脉的活体显微镜研究中,我们显示ADO通过位于EC上的A2A受体起作用,通过激活位于血管平滑肌细胞上的KATP通道来产生血管舒张作用。重要的是,我们发现信号通路如预期的那样涉及cAMP,但是只有在血管未预先暴露于ADO的情况下,才能证明PKA激活的要求。即,依赖PKA的信令随对ADO的预暴露而变化。此外,我们表明,仅PKA激活不足以扩张这些小动脉。血管舒张至ADO还需要其他EC钙依赖性信号传导机制。通过在不同条件下利用不同的细胞信号传导途径产生相同反应的小动脉原位对特定受体占用的反应能力,使小动脉可以使用多种信号机制来响应关键的稳态需求。显然,这可能在生理上是有利的,但是这种信号灵活性在功能性充血基础的小动脉综合反应中的作用将需要进一步探索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号